Effect and safety of diluted vasopressin injection on bleeding during robot-assisted laparoscopic myomectomy: a protocol for a randomised controlled pilot trial

Eun Ji Lee, Soo Jin Park, Yup Kim, Hyunji Lim, Seungmee Lee, Ga Won Yim, Gwonhwa Song, Hee Seung Kim, Eun Ji Lee, Soo Jin Park, Yup Kim, Hyunji Lim, Seungmee Lee, Ga Won Yim, Gwonhwa Song, Hee Seung Kim

Abstract

Introduction: Even though the injection of diluted vasopressin into the uterus is expected to reduce intraoperative bleeding with decreased adverse effects during robot-assisted laparoscopic myomectomy (RALM), there is a lack of relevant trials to show its effect and safety. Thus, this study was designed to compare the effect and safety of vasopressin injection on bleedings based on dilution levels of vasopressin with constant volumes during RALM.

Methods and analysis: This is a randomised controlled pilot trial, where a total of 39 patients will be randomly divided into three experimental groups in a 1:1:1 ratio. All patients will be classified into the three groups based on the dilution level of vasopressin: group 1-a solution prepared by mixing 20 units of vasopressin with 100 mL of normal saline to make a total of 100 mL; group 2-a solution prepared by mixing 20 units of vasopressin with 200 mL of normal saline to make a total of 100 mL and group 3-a solution prepared by mixing 20 units of vasopressin with 400 mL of normal saline to make a total of 100 mL. During RALM, we will inject diluted vasopressin at different concentrations with a total of 100 mL. As the primary endpoint, estimated blood loss would be compared. As secondary endpoints, we will check the level of haemoglobin and haematocrit, operation time, amount of transfusion, and the period of hospitalisation. In addition, we will check other complications related to vasopressin injection.

Ethics and dissemination: This pilot study has been approved by the Institutional Review Board of the Seoul National University Hospital (No. H-2011-107-1174). All potential subjects will be provided written informed consent. The results of this study will be published in peer-reviewed journals and be presented at academic conferences.

Trial registration numbers: NCT04874246 and CKCT0006225.

Keywords: adult anaesthesia; gynaecology; minimally invasive surgery.

Conflict of interest statement

Competing interests: HSK, the corresponding author received research support from the MEDITECH INFRAMED Corp. (Seoul, Republic of Korea). Moreover, he is the Chief Executive Officer (CEO) in Dreampac Corp. (Wonju, Republic of Korea), and the Chief Financial Officer (CFO) in Precision Medicine for Peritoneal Metastasis Corp. (Wonju, Repblic of Korea). No other authors has reported a potential conflict of interest relevant to this article.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Flow diagram of the study.

References

    1. Pavone D, Clemenza S, Sorbi F, et al. . Epidemiology and risk factors of uterine fibroids.. Best Pract Res Clin Obstet Gynaecol 2018;46:3–11. 10.1016/j.bpobgyn.2017.09.004
    1. Mais V, Ajossa S, Guerriero S, et al. . Laparoscopic versus abdominal myomectomy: a prospective, randomized trial to evaluate benefits in early outcome. Am J Obstet Gynecol 1996;174:654–8. 10.1016/S0002-9378(96)70445-3
    1. Arian SE, Munoz JL, Kim S, et al. . Robot-Assisted laparoscopic myomectomy: current status. Robot Surg 2017;4:7–18. 10.2147/RSRR.S102743
    1. Kim H, Shim S, Hwang Y, et al. . Is robot-assisted laparoscopic myomectomy limited in multiple myomas?: a feasibility for ten or more myomas. Obstet Gynecol Sci 2018;61:135–41. 10.5468/ogs.2018.61.1.135
    1. Dillon TF, Marbury BE, Bonsnes RW, et al. . Vasopressin as a hemostatic in gynecologic surgery; a preliminary report. Obstet Gynecol 1958;11:363–71.
    1. Fletcher H, Frederick J, Hardie M, et al. . A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy. Obstet Gynecol 1996;87:1014–8. 10.1016/0029-7844(96)00071-3
    1. Muthukumar M, Mathews L, Vasantha N, et al. . Intramyometrial vasopressin as a haemostatic agent: is it really safe? Indian J Anaesth 2015;59:51–3. 10.4103/0019-5049.149456
    1. Riess ML, Ulrichs JG, Pagel PS, et al. . Severe vasospasm mimics hypotension after high-dose intrauterine vasopressin. Anesth Analg 2011;113:1103–5. 10.1213/ANE.0b013e31822cef10
    1. Liedman R, Grant L, Igidbashian S, et al. . Intrauterine pressure, ischemia markers, and experienced pain during administration of a vasopressin V1a receptor antagonist in spontaneous and vasopressin-induced dysmenorrhea. Acta Obstet Gynecol Scand 2006;85:207–11. 10.1080/00016340500495082
    1. Jayaraman L, Sinha A, Punhani D. Intramyometrial vasopressin: Anesthesiologists' nightmare. J Anaesthesiol Clin Pharmacol 2013;29:135–6. 10.4103/0970-9185.105832
    1. Nerurkar A, Laheri V, Thakare D, et al. . Bradycardia, absent radial pulse and convulsion following intramyometrial vasopressin. J Anaesthesiol Clin Pharmacol 2010;26:109. 10.4103/0970-9185.75138
    1. Hobo R, Netsu S, Koyasu Y, et al. . Bradycardia and cardiac arrest caused by intramyometrial injection of vasopressin during a laparoscopically assisted myomectomy. Obstet Gynecol 2009;113:484–6. 10.1097/AOG.0b013e318187e795
    1. Kim SY, Lee JH, Bang EC. Pulmonary edema following intramyometrial injection and paracervical infiltration of vasopressin during laparoscopic myomectomy and LAVH (laparoscopic abdominal vaginal hysterectomy): a report of 2 cases. Anesth Pain Med 2010;5:333–7.
    1. Cohen SL, Senapati S, Gargiulo AR, et al. . Dilute versus concentrated vasopressin administration during laparoscopic myomectomy: a randomised controlled trial. BJOG 2017;124:262–8. 10.1111/1471-0528.14179
    1. Moon HS, Kim SG, Park GS, et al. . Efficacy of bleeding control using a large amount of highly diluted vasopressin in laparoscopic treatment for interstitial pregnancy. Am J Obstet Gynecol 2010;203:30.e1–30.e6. 10.1016/j.ajog.2010.02.030
    1. Zhao F, Jiao Y, Guo Z, et al. . Evaluation of loop ligation of larger Myoma pseudocapsule combined with vasopressin on laparoscopic myomectomy. Fertil Steril 2011;95:762–6. 10.1016/j.fertnstert.2010.08.059
    1. Chan A-W, Tetzlaff JM, Gøtzsche PC, et al. . SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:e7586. 10.1136/bmj.e7586
    1. Moher D, Hopewell S, Schulz KF, et al. . CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c869. 10.1136/bmj.c869
    1. Jones HW, Rock JA. Te Linde’s operative gynecology. Lippincott Williams & Wilkins, 2015.
    1. ACOG Committee on Practice Bulletins-Gynecology. . ACOG practice bulletin. surgical alternatives to hysterectomy in the management of leiomyomas. number 16, may 2000 (replaces educational bulletin number 192, may 1994). Int J Gynaecol Obstet 2001;73:285–93. 10.1016/s0020-7292(01)00414-3
    1. Kongnyuy EJ, Wiysonge CS. Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database Syst Rev 2011;11:CD005355.
    1. Ginsburg ES, Benson CB, Garfield JM, et al. . The effect of operative technique and uterine size on blood loss during myomectomy: a prospective randomized study. Fertil Steril 1993;60:956–62.
    1. Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat 2005;4:287–91. 10.1002/pst.185
    1. Assaf A. Adhesions after laparoscopic myomectomy: effect of the technique used. Gynaecological Endoscopy 1999;8:225–9. 10.1046/j.1365-2508.1999.00246.x

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner